Policy Implications of the IOM’s Evaluation of PEPFAR

Policy Implications of the IOM’s Evaluation of PEPFAR

On Tuesday, April 30, The Kaiser Family Foundation and the CSIS Global Health Policy Center held an event titled The Policy Implications of the Institute of Medicine’s Evaluation of PEPFAR.

The Institute of Medicine’s recently completed Evaluation of PEPFAR assesses the program’s performance over the past decade, as it transitioned from an emergency response to the HIV/AIDS epidemic to an emphasis on strengthening health systems in focal countries. The Evaluation of PEPFAR was a four-year, congressionally mandated review of PEPFAR; it is only the second major review of the program.  For this occasion, representatives convened from the U.S. administration, evaluation participants, and independent experts to discuss the review’s implications for PEPFAR’s policy priorities in the second Obama term.

View Webcast

Speakers included:

Chris Collins
Vice President; Director, Public Policy
amfAR, The Foundation for AIDS Research

Jennifer Kates
Vice President; Director, Global Health and HIV Policy
Kaiser Family Foundation

Julia Martin
Deputy Global AIDS Coordinator
Office of the Global AIDS Coordinator

Kimberly Scott
Senior Program Officer
Institute of Medicine

Moderated by:
J. Stephen Morrison
Vice President; and Director, Global Health Policy Center
Center for Strategic and International Studies

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.